Cardiorenal outcomes with sodium/glucose cotransporter-2 inhibitors in patients with type 2 diabetes and low kidney risk: real world evidence
暂无分享,去创建一个
G. Chodick | A. Karasik | M. Kosiborod | Ofri Mosenzon | Meir Schechter | Cheli Melzer-Cohen | Aliza Rozenberg | Ilan Yanuv